Signum Surgical USA

Open enrollment across a mixed-phase pipeline

According to ClinicalTrials.gov-derived indexes, Signum Surgical USA sits in the upper half of US sponsors by registered trial count (#7,388 of 15,742 sponsors by registered trial count).

1 total trials 1 currently recruiting upper half by trial count

Signum Surgical USA: 1 sponsored US clinical trial, 1 recruiting.

Signum Surgical USA sponsors 1 registered US clinical trials on ClinicalTrials.gov, 1 of them currently recruiting. The most-studied condition in this pipeline is Fistula-in-ano, with 1 trials.

Mid-pack sponsor footprint

Signum Surgical USA is in the upper half of sponsors by trial count (#7,388 of 15,742 sponsors by registered trial count). Use the pipeline list and therapeutic areas to see what drives that mid-pack volume.

Open and recent trials

1 total, page 1 of 1

RECRUITING

BioHealx® Anal Fistula Device Post Market Surveillance Study

NCT07021742

Therapeutic Areas

Fistula-in-ano 1

What is open in the Signum Surgical USA pipeline

1 recruiting of 1 indexed (100% open).

Phase labels are sparse on this sponsor index, so phase mix is not charted here.

Top condition: Fistula-in-ano (1 trial), 0 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

Signum Surgical USA: open-pipeline peers nationwide

Peers matched on 1 registered trials and 100% open enrollment, not the therapeutic-area sidebar.

Signum Surgical USA sits below the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 012345 0%50%100%150% Total trials Recruiting share Signum Surgical USA1200 Pharma1ST Biotherapeutics3 Waves Wellness3EO HealthAAVantgarde Bio SrlAcorn BiolabsAcrivon TherapeuticsADARx Pharmaceuticals
Signum Surgical USA sits below the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

Signum Surgical USA sits below the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 1 trials (± recruiting share)

Sponsors near 100% open enrollment (± trial volume)

Related

Read our methodology - how this data is sourced, computed, and verified.

What to do with this Signum Surgical USA page

1 registered trials is a research-attention snapshot, not an endorsement of Signum Surgical USA or any single study.

  • 1 of Signum Surgical USA's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
  • Fistula-in-ano is the condition Signum Surgical USA studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Fistula-in-ano trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Signum Surgical USA pipeline card: 1 registered trials from official public datasets.Report a data error.